Every Indian IPO in one place. We score each one, and show how often we were right.
GMP is an informal figure from outside SEBI's framework. Not investment advice.
Molbio Diagnostics is a Mainboard issue priced at ₹807 a share. One lot is 18 shares, which costs ₹14,526. The book is 70.27 times subscribed overall. The grey market premium is +₹145 (+18.0%), which is an informal figure and not a quoted price. Our call is Risky, on 78% of our checks.